☰

Peter A. Calabresi - Publications

Affiliations: 
Neurology Johns Hopkins University, Baltimore, MD 
Area:
multiple sclerosis
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

306 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Bagnato F, Sati P, Hemond CC, Elliott C, Gauthier SA, Harrison DM, Mainero C, Oh J, Pitt D, Shinohara RT, Smith SA, Trapp B, Azevedo CJ, Calabresi PA, Henry RG, et al. Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain : a Journal of Neurology. PMID 38226694 DOI: 10.1093/brain/awae013  0.578
2023 Daboul L, O'Donnell CM, Amin M, Rodrigues P, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi PA, Cree BA, Freeman L, Henry RG, Longbrake EE, Oh J, Papinutto N, et al. A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231214360. PMID 38088067 DOI: 10.1177/13524585231214360  0.566
2023 Ladakis DC, Reyes-Mantilla MI, Gadani SP, Mace JW, Dominguez-Penuela SC, Appiah MJ, Smith MD, Bhargava P, Fox RJ, Saidha S, Calabresi PA. Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231213164. PMID 37982154 DOI: 10.1177/13524585231213164  0.754
2023 Thompson AJ, Moccia M, Amato MP, Calabresi PA, Finlayson M, Hawton A, Lublin FD, Marrie RA, Montalban X, Panzara M, Sormani MP, Strum J, Vickrey BG, Coetzee T. Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231196786. PMID 37691493 DOI: 10.1177/13524585231196786  0.33
2023 Gadani SP, Calabresi PA. The calvaria stands alone: Unique aspects of the skull bone marrow-meninges border. Cell. 186: 3524-3526. PMID 37595561 DOI: 10.1016/j.cell.2023.07.025  0.663
2023 Clark KA, O'Donnell CM, Elliott MA, Tauhid S, Dewey BE, Chu R, Khalil S, Nair G, Sati P, DuVal A, Pellegrini N, Bar-Or A, Markowitz C, Schindler MK, Zurawski J, ... Calabresi PA, et al. Intersite brain MRI volumetric biases persist even in a harmonized multisubject study of multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 37587544 DOI: 10.1111/jon.13147  0.566
2023 Newsome SD, Tian F, Shoemaker T, Fitzgerald KC, Cassard SD, Fiol J, Snoops S, Cooper DS, Mammen JSR, Bhargava P, Mowry EM, Calabresi PA. A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 37460763 DOI: 10.1007/s13311-023-01402-3  0.328
2023 Ehrhardt H, Lambe J, Moussa H, Vasileiou ES, Kalaitzidis G, Murphy OC, Filippatou AG, Pellegrini N, Douglas M, Davis S, Nagy N, Quiroga A, Hu C, Zambriczki Lee A, Duval A, ... ... Calabresi PA, et al. Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post-Hoc Analyses of the SPRINT-MS Trial. Neurology. PMID 37460235 DOI: 10.1212/WNL.0000000000207551  0.364
2023 Maggi P, Bulcke CV, Pedrini E, Bugli C, Sellimi A, Wynen M, Stölting A, Mullins WA, Kalaitzidis G, Lolli V, Perrotta G, El Sankari S, Duprez T, Li X, Calabresi PA, et al. B cell depletion therapy does not resolve chronic active multiple sclerosis lesions. Ebiomedicine. 94: 104701. PMID 37437310 DOI: 10.1016/j.ebiom.2023.104701  0.551
2023 Gill AJ, Schorr EM, Gadani SP, Calabresi PA. Emerging imaging and liquid biomarkers in multiple sclerosis. European Journal of Immunology. e2250228. PMID 37194443 DOI: 10.1002/eji.202250228  0.756
2023 Chen AA, Clark K, Dewey B, DuVal A, Pellegrini N, Nair G, Jalkh Y, Khalil S, Zurawski J, Calabresi P, Reich D, Bakshi R, Shou H, Shinohara RT. Deconfounded Dimension Reduction via Partial Embeddings. Biorxiv : the Preprint Server For Biology. PMID 36711940 DOI: 10.1101/2023.01.10.523448  0.414
2022 Gharagozloo M, Mace JW, Calabresi PA. Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis. Frontiers in Molecular Neuroscience. 15: 995477. PMID 36407761 DOI: 10.3389/fnmol.2022.995477  0.315
2022 Daboul L, O'Donnell CM, Cao Q, Amin M, Rodrigues P, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi P, Cree BAC, Freeman L, Henry RG, Longbrake EE, Nakamura K, et al. Effect of GBCA Use on Detection and Diagnostic Performance of the Central Vein Sign: Evaluation Using a 3T FLAIR* Sequence in Patients With Suspected Multiple Sclerosis. Ajr. American Journal of Roentgenology. PMID 35975888 DOI: 10.2214/AJR.22.27731  0.589
2022 Lee S, Plavina T, Singh CM, Xiong K, Qiu X, Rudick RA, Calabresi PA, Stevenson L, Graham D, Raitcheva D, Green C, Matias M, Uzgiris AJ. Development of a Highly Sensitive Neurofilament Light Chain Assay on an Automated Immunoassay Platform. Frontiers in Neurology. 13: 935382. PMID 35959400 DOI: 10.3389/fneur.2022.935382  0.306
2022 Thomas AM, Yang E, Smith MD, Chu C, Calabresi PA, Glunde K, van Zijl PCM, Bulte JWM. CEST MRI and MALDI imaging reveal metabolic alterations in the cervical lymph nodes of EAE mice. Journal of Neuroinflammation. 19: 130. PMID 35659311 DOI: 10.1186/s12974-022-02493-z  0.316
2021 Gadani SP, Reyes-Mantilla M, Jank L, Harris S, Douglas M, Smith MD, Calabresi PA, Mowry EM, Fitzgerald KC, Bhargava P. Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy. Ebiomedicine. 73: 103636. PMID 34666226 DOI: 10.1016/j.ebiom.2021.103636  0.713
2021 Absinta M, Maric D, Gharagozloo M, Garton T, Smith MD, Jin J, Fitzgerald KC, Song A, Liu P, Lin JP, Wu T, Johnson KR, McGavern DB, Schafer DP, Calabresi PA, et al. A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis. Nature. PMID 34497421 DOI: 10.1038/s41586-021-03892-7  0.584
2021 Gharagozloo M, Smith MD, Jin J, Garton T, Taylor M, Chao A, Meyers K, Kornberg MD, Zack DJ, Ohayon J, Calabresi BA, Reich DS, Eberhart CG, Pardo CA, Kemper C, ... ... Calabresi PA, et al. Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation. Acta Neuropathologica. PMID 34487221 DOI: 10.1007/s00401-021-02366-4  0.527
2021 Gadani SP, Reyes-Mantilla M, Jank L, Harris S, Douglas M, Smith MD, Calabresi PA, Mowry EM, Fitzgerald KC, Bhargava P. Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy. Medrxiv : the Preprint Server For Health Sciences. PMID 34462762 DOI: 10.1101/2021.08.23.21262472  0.712
2021 Schirmer L, Schafer DP, Bartels T, Rowitch DH, Calabresi PA. Diversity and Function of Glial Cell Types in Multiple Sclerosis. Trends in Immunology. PMID 33593693 DOI: 10.1016/j.it.2021.01.005  0.316
2020 Murphy OC, Kalaitzidis G, Vasileiou E, Filippatou AG, Lambe J, Ehrhardt H, Pellegrini N, Sotirchos ES, Luciano NJ, Liu Y, Fitzgerald KC, Prince JL, Calabresi PA, Saidha S. Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings After Optic Neuritis in Multiple Sclerosis. Frontiers in Neurology. 11: 618879. PMID 33384660 DOI: 10.3389/fneur.2020.618879  0.347
2020 Fritz NE, Edwards EM, Keller J, Eloyan A, Calabresi PA, Zackowski KM. Combining Magnetization Transfer Ratio MRI and Quantitative Measures of Walking Improves the Identification of Fallers in MS. Brain Sciences. 10. PMID 33171942 DOI: 10.3390/brainsci10110822  0.324
2020 Zhao C, Dewey BE, Pham DL, Calabresi PA, Reich DS, Prince JL. SMORE: A Self-supervised Anti-aliasing and Super-resolution Algorithm for MRI Using Deep Learning. Ieee Transactions On Medical Imaging. PMID 33170776 DOI: 10.1109/TMI.2020.3037187  0.458
2020 Maggi P, Sati P, Nair G, Cortese ICM, Jacobson S, Smith BR, Nath A, Ohayon J, van Pesch V, Perrotta G, Pot C, Théaudin M, Martinelli V, Scotti R, Wu T, ... ... Calabresi PA, et al. PARAMAGNETIC RIM LESIONS ARE SPECIFIC TO MULTIPLE SCLEROSIS: AN INTERNATIONAL MULTICENTER 3T MRI STUDY. Annals of Neurology. PMID 32799417 DOI: 10.1002/Ana.25877  0.638
2020 Wrobel J, Martin ML, Bakshi R, Calabresi PA, Elliot M, Roalf D, Gur RC, Gur RE, Henry RG, Nair G, Oh J, Papinutto N, Pelletier D, Reich DS, Rooney WD, et al. Intensity warping for multisite MRI harmonization. Neuroimage. 117242. PMID 32798678 DOI: 10.1016/J.Neuroimage.2020.117242  0.522
2020 Morales Pantoja IE, Smith MD, Rajbhandari L, Cheng L, Gao Y, Mahairaki V, Venkatesan A, Calabresi PA, Fitzgerald KC, Whartenby KA. iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu. Plos One. 15: e0233980. PMID 32511247 DOI: 10.1371/Journal.Pone.0233980  0.41
2020 Oh J, Chen M, Cybulsky K, Suthiphosuwan S, Seyman E, Dewey B, Diener-West M, van Zijl P, Prince J, Reich DS, Calabresi PA. Five-year longitudinal changes in quantitative spinal cord MRI in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520923970. PMID 32476593 DOI: 10.1177/1352458520923970  0.557
2020 Orthmann-Murphy J, Call CL, Molina-Castro GC, Hsieh YC, Rasband MN, Calabresi PA, Bergles DE. Remyelination alters the pattern of myelin in the cerebral cortex. Elife. 9. PMID 32459173 DOI: 10.7554/Elife.56621  0.34
2020 Valcarcel AM, Muschelli J, Pham DL, Martin ML, Yushkevich P, Brandstadter R, Patterson KR, Schindler MK, Calabresi PA, Bakshi R, Shinohara RT. TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple Sclerosis. Neuroimage. Clinical. 27: 102256. PMID 32428847 DOI: 10.1016/J.Nicl.2020.102256  0.355
2020 Carass A, Roy S, Gherman A, Reinhold JC, Jesson A, Arbel T, Maier O, Handels H, Ghafoorian M, Platel B, Birenbaum A, Greenspan H, Pham DL, Crainiceanu CM, Calabresi PA, et al. Evaluating White Matter Lesion Segmentations with Refined Sørensen-Dice Analysis. Scientific Reports. 10: 8242. PMID 32427874 DOI: 10.1038/S41598-020-64803-W  0.393
2020 Bagnato F, Gauthier SA, Laule C, Moore GRW, Bove R, Cai Z, Cohen-Adad J, Harrison DM, Klawiter EC, Morrow SA, Öz G, Rooney WD, Smith SA, Calabresi PA, Henry RG, et al. Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 30: 251-266. PMID 32418324 DOI: 10.1111/Jon.12700  0.604
2020 Thomas AM, Li S, Chu C, Shats I, Xu J, Calabresi PA, van Zijl PCM, Walczak P, Bulte JWM. Evaluation of cell transplant-mediated attenuation of diffuse injury in experimental autoimmune encephalomyelitis using onVDMP CEST MRI. Experimental Neurology. 113316. PMID 32304749 DOI: 10.1016/J.Expneurol.2020.113316  0.338
2020 Filippatou AG, Lambe J, Sotirchos ES, Fitzgerald KC, Aston A, Murphy OC, Pellegrini N, Fioravante N, Risher H, Ogbuokiri E, Kwakyi O, Toliver B, Davis S, Luciano N, Crainiceanu C, ... ... Calabresi PA, et al. Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519900942. PMID 32297826 DOI: 10.1177/1352458519900942  0.375
2020 Dietrich M, Koska V, Hecker C, Göttle P, Hilla AM, Heskamp A, Lepka K, Issberner A, Hallenberger A, Baksmeier C, Steckel J, Balk L, Knier B, Korn T, Havla J, ... ... Calabresi PA, et al. Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis. Brain : a Journal of Neurology. PMID 32293668 DOI: 10.1093/Brain/Awaa062  0.377
2020 Sotirchos ES, Caldito NG, Filippatou A, Fitzgerald KC, Murphy OC, Lambe J, Nguyen J, Button J, Ogbuokiri E, Crainiceanu CM, Prince JL, Calabresi PA, Saidha S. Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy. Annals of Neurology. PMID 32285484 DOI: 10.1002/Ana.25738  0.42
2020 Bhargava P, Smith MD, Mische L, Harrington EP, Fitzgerald KC, Martin KA, Kim S, Reyes AAA, Gonzalez-Cardona J, Volsko C, Tripathi A, Singh S, Varanasi K, Lord HN, Meyers KR, ... ... Calabresi PA, et al. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation. The Journal of Clinical Investigation. PMID 32182223 DOI: 10.1172/Jci129401  0.396
2020 Wang Y, Tian F, Fitzgerald KC, Bhattarai JJ, Naismith RT, Hyland M, Calabresi PA, Mowry EM. Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis. Multiple Sclerosis and Related Disorders. 41: 102010. PMID 32088654 DOI: 10.1016/J.Msard.2020.102010  0.361
2019 Sabatino JJ, Wilson MR, Calabresi PA, Hauser SL, Schneck JP, Zamvil SS. Anti-CD20 therapy depletes activated myelin-specific CD8 T cells in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31748274 DOI: 10.1073/Pnas.1915309116  0.368
2019 Harrington EP, Bergles DE, Calabresi PA. Immune cell modulation of oligodendrocyte lineage cells. Neuroscience Letters. 134601. PMID 31693930 DOI: 10.1016/J.Neulet.2019.134601  0.38
2019 He Y, Carass A, Liu Y, Jedynak BM, Solomon SD, Saidha S, Calabresi PA, Prince JL. Deep learning based topology guaranteed surface and MME segmentation of multiple sclerosis subjects from retinal OCT. Biomedical Optics Express. 10: 5042-5058. PMID 31646029 DOI: 10.1364/Boe.10.005042  0.355
2019 Thomas AM, Xu J, Calabresi PA, van Zijl PCM, Bulte JWM. Monitoring diffuse injury during disease progression in experimental autoimmune encephalomyelitis with on resonance variable delay multiple pulse (onVDMP) CEST MRI. Neuroimage. 116245. PMID 31605825 DOI: 10.1016/J.Neuroimage.2019.116245  0.471
2019 Gharagozloo M, Mahmoud S, Simard C, Yamamoto K, Bobbala D, Ilangumaran S, Smith MD, Lamontagne A, Jarjoura S, Denault JB, Blais V, Gendron L, Vilariño-Güell C, Sadovnick AD, Ting JP, ... Calabresi PA, et al. NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity. Plos Biology. 17: e3000451. PMID 31525189 DOI: 10.1371/Journal.Pbio.3000451  0.36
2019 Gonzalez Cardona J, Smith MD, Wang J, Kirby L, Schott JT, Davidson T, Karnell JL, Whartenby KA, Calabresi PA. Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis. Plos One. 14: e0221747. PMID 31490950 DOI: 10.1371/Journal.Pone.0221747  0.404
2019 Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, Davidson T, Dutta R, Goverman J, Bergles D, Calabresi PA. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nature Communications. 10: 3887. PMID 31467299 DOI: 10.1038/S41467-019-11638-3  0.434
2019 Hollinger KR, Smith MD, Kirby LA, Prchalova E, Alt J, Rais R, Calabresi PA, Slusher BS. Glutamine antagonism attenuates physical and cognitive deficits in a model of MS. Neurology(R) Neuroimmunology & Neuroinflammation. 6. PMID 31467038 DOI: 10.1212/Nxi.0000000000000609  0.348
2019 Beecham AH, Amezcua L, Chinea A, Manrique CP, Rubi C, Isobe N, Lund BT, Santaniello A, Beecham GW, Burchard EG, Comabella M, Patsopoulos N, Fitzgerald K, Calabresi PA, De Jager P, et al. The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519863764. PMID 31368393 DOI: 10.1177/1352458519863764  0.301
2019 Jin J, Smith MD, Kersbergen CJ, Kam TI, Viswanathan M, Martin K, Dawson TM, Dawson VL, Zack DJ, Whartenby K, Calabresi PA. Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis. Acta Neuropathologica Communications. 7: 125. PMID 31366377 DOI: 10.1186/S40478-019-0767-6  0.415
2019 Sotirchos ES, Filippatou A, Fitzgerald KC, Salama S, Pardo S, Wang J, Ogbuokiri E, Cowley NJ, Pellegrini N, Murphy OC, Mealy MA, Prince JL, Levy M, Calabresi PA, Saidha S. Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519864928. PMID 31364464 DOI: 10.1177/1352458519864928  0.342
2019 Dewey BE, Zhao C, Reinhold JC, Carass A, Fitzgerald KC, Sotirchos ES, Saidha S, Oh J, Pham DL, Calabresi PA, van Zijl PCM, Prince JL. DeepHarmony: A deep learning approach to contrast harmonization across scanner changes. Magnetic Resonance Imaging. PMID 31301354 DOI: 10.1016/J.Mri.2019.05.041  0.328
2019 Fitzgerald KC, Kim K, Smith MD, Aston SA, Fioravante N, Rothman AM, Krieger S, Cofield SS, Kimbrough DJ, Bhargava P, Saidha S, Whartenby KA, Green AJ, Mowry EM, Cutter GR, ... ... Calabresi PA, et al. Early complement genes are associated with visual system degeneration in multiple sclerosis. Brain : a Journal of Neurology. PMID 31289819 DOI: 10.1093/Brain/Awz188  0.377
2019 Cadavid D, Mellion M, Hupperts R, Edwards KR, Calabresi PA, Drulović J, Giovannoni G, Hartung HP, Arnold DL, Fisher E, Rudick R, Mi S, Chai Y, Li J, Zhang Y, et al. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial. The Lancet. Neurology. PMID 31285147 DOI: 10.1016/S1474-4422(19)30137-1  0.355
2019 Zhao C, Shao M, Carass A, Li H, Dewey BE, Ellingsen LM, Woo J, Guttman MA, Blitz AM, Stone M, Calabresi PA, Halperin H, Prince JL. Applications of a deep learning method for anti-aliasing and super-resolution in MRI. Magnetic Resonance Imaging. PMID 31247254 DOI: 10.1016/J.Mri.2019.05.038  0.342
2019 Murphy OC, Kwakyi O, Iftikhar M, Zafar S, Lambe J, Pellegrini N, Sotirchos ES, Gonzalez-Caldito N, Ogbuokiri E, Filippatou A, Risher H, Cowley N, Feldman S, Fioravante N, Frohman EM, ... ... Calabresi PA, et al. Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519845116. PMID 31094280 DOI: 10.1177/1352458519845116  0.439
2019 Newsome SD, von Geldern G, Shou H, Baynes M, Marasigan RER, Calabresi PA, Zackowski KM. Longitudinal assessment of hand function in individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders. 32: 107-113. PMID 31085489 DOI: 10.1016/J.Msard.2019.04.035  0.379
2019 Nguyen J, Rothman A, Gonzalez N, Avornu A, Ogbuokiri E, Balcer LJ, Galetta SL, Frohman EM, Frohman T, Crainiceanu C, Calabresi PA, Saidha S. Macular Ganglion Cell and Inner Plexiform Layer Thickness Is More Strongly Associated With Visual Function in Multiple Sclerosis Than Bruch Membrane Opening-Minimum Rim Width or Peripapillary Retinal Nerve Fiber Layer Thicknesses. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. PMID 30921169 DOI: 10.1097/Wno.0000000000000768  0.366
2019 Fritz NE, Eloyan A, Glaister J, Dewey BE, Al-Louzi O, Costello MG, Chen M, Prince JL, Calabresi PA, Zackowski KM. Quantitative vibratory sensation measurement is related to sensory cortical thickness in MS. Annals of Clinical and Translational Neurology. 6: 586-595. PMID 30911581 DOI: 10.1002/Acn3.734  0.333
2019 Liu Y, Carass A, He Y, Antony BJ, Filippatou A, Saidha S, Solomon SD, Calabresi PA, Prince JL. Layer boundary evolution method for macular OCT layer segmentation. Biomedical Optics Express. 10: 1064-1080. PMID 30891330 DOI: 10.1364/Boe.10.001064  0.349
2019 Nolan RC, Liu M, Akhand O, Calabresi PA, Paul F, Petzold A, Balk L, Brandt AU, Martínez-Lapiscina EH, Saidha S, Villoslada P, Al-Hassan AA, Behbehani R, Frohman EM, Frohman T, et al. Optimal Inter-Eye Difference Thresholds by OCT in MS: An International Study. Annals of Neurology. PMID 30851125 DOI: 10.1002/Ana.25462  0.362
2019 Rothman A, Murphy OC, Fitzgerald KC, Button J, Gordon-Lipkin E, Ratchford JN, Newsome SD, Mowry EM, Sotirchos ES, Syc-Mazurek SB, Nguyen J, Caldito NG, Balcer LJ, Frohman EM, Frohman TC, ... ... Calabresi PA, et al. Retinal measurements predict 10-year disability in multiple sclerosis. Annals of Clinical and Translational Neurology. 6: 222-232. PMID 30847355 DOI: 10.1002/Acn3.674  0.593
2019 Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, et al. Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS. Neurology. PMID 30787160 DOI: 10.1212/Wnl.0000000000007099  0.598
2019 Bhargava P, Wicken C, Smith MD, Strowd RE, Cortese I, Reich DS, Calabresi PA, Mowry EM. Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement. Multiple Sclerosis and Related Disorders. 30: 136-140. PMID 30771580 DOI: 10.1016/J.Msard.2019.02.013  0.61
2019 Sotirchos ES, Gonzalez-Caldito N, Dewey BE, Fitzgerald KC, Glaister J, Filippatou A, Ogbuokiri E, Feldman S, Kwakyi O, Risher H, Crainiceanu C, Pham DL, Van Zijl PC, Mowry EM, Reich DS, ... ... Calabresi PA, et al. Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519826364. PMID 30741108 DOI: 10.1177/1352458519826364  0.602
2019 He Y, Carass A, Solomon SD, Saidha S, Calabresi PA, Prince JL. Retinal layer parcellation of optical coherence tomography images: Data resource for multiple sclerosis and healthy controls. Data in Brief. 22: 601-604. PMID 30671506 DOI: 10.1016/J.Dib.2018.12.073  0.377
2019 Schwartz DL, Tagge I, Powers K, Ahn S, Bakshi R, Calabresi PA, Todd Constable R, Grinstead J, Henry RG, Nair G, Papinutto N, Pelletier D, Shinohara R, Oh J, Reich DS, et al. Multisite reliability and repeatability of an advanced brain MRI protocol. Journal of Magnetic Resonance Imaging : Jmri. PMID 30652391 DOI: 10.1002/Jmri.26652  0.541
2019 Iftikhar M, Zafar S, Gonzales N, Murphy O, Ohemaa Kwakyi MS, Sydney Feldman BS, Calabresi PA, Saidha S, Channa R. Image Artifacts In Optical Coherence Tomography Angiography Among Patients With Multiple Sclerosis. Current Eye Research. PMID 30624088 DOI: 10.1080/02713683.2019.1565892  0.447
2019 Zhu B, Calabresi PA, Giovanonni G, Kapoor R, Naismith R, Hartung H, Arnold DL, Wolstencroft P, Johnson K. 200 AFFINITY: opicinumab in a targeted population of MS patients Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn-2.169  0.444
2018 Zhao C, Carass A, Dewey BE, Woo J, Oh J, Calabresi PA, Reich DS, Sati P, Pham DL, Prince JL. A Deep Learning Based Anti-aliasing Self Super-resolution Algorithm for MRI. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 11070: 100-108. PMID 38013916 DOI: 10.1007/978-3-030-00928-1_12  0.445
2018 Filippatou A, Shoemaker T, Esch M, Qutab M, Gonzalez-Caldito N, Prince JL, Mowry EM, Calabresi PA, Saidha S, Sotirchos ES. Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518815597. PMID 30507269 DOI: 10.1177/1352458518815597  0.338
2018 Balcer LJ, Balk LJ, Brandt AU, Calabresi PA, Martinez-Lapiscina EH, Nolan RC, Paul F, Petzold A, Saidha S. The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 38: 494-501. PMID 30418332 DOI: 10.1097/Wno.0000000000000732  0.371
2018 Caldito NG, Saidha S, Sotirchos ES, Dewey BE, Cowley NJ, Glaister J, Fitzgerald KC, Al-Louzi O, Nguyen J, Rothman A, Ogbuokiri E, Fioravante N, Feldman S, Kwakyi O, Risher H, ... ... Calabresi PA, et al. Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study. Brain : a Journal of Neurology. PMID 30312381 DOI: 10.1093/Brain/Awy245  0.584
2018 Nguyen J, Rothman A, Fitzgerald K, Whetstone A, Syc-Mazurek S, Aquino J, Balcer LJ, Frohman EM, Frohman T, Crainiceanu C, Beier M, Newsome SD, Calabresi PA, Saidha S. Visual pathway measures are associated with neuropsychological function in MS. Current Eye Research. PMID 29634379 DOI: 10.1080/02713683.2018.1459730  0.374
2018 Valcarcel AM, Linn KA, Vandekar SN, Satterthwaite TD, Muschelli J, Calabresi PA, Pham DL, Martin ML, Shinohara RT. MIMoSA: An Automated Method for Intermodal Segmentation Analysis of Multiple Sclerosis Brain Lesions. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 29516669 DOI: 10.1111/Jon.12506  0.418
2018 Miller AE, Calabresi PA. Central vein sign in multiple sclerosis: Ready for front and center? Neurology. PMID 29514945 DOI: 10.1212/Wnl.0000000000005241  0.424
2018 Dworkin JD, Linn KA, Oguz I, Fleishman GM, Bakshi R, Nair G, Calabresi PA, Henry RG, Oh J, Papinutto N, Pelletier D, Rooney W, Stern W, Sicotte NL, Reich DS, et al. An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions. Ajnr. American Journal of Neuroradiology. PMID 29472300 DOI: 10.3174/Ajnr.A5556  0.549
2018 Kornberg MD, Smith MD, Shirazi HA, Calabresi PA, Snyder SH, Kim PM. Bryostatin-1 alleviates experimental multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 29440425 DOI: 10.1073/Pnas.1719902115  0.443
2018 Nolan RC, Galetta SL, Frohman TC, Frohman EM, Calabresi PA, Castrillo-Viguera C, Cadavid D, Balcer LJ. Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. PMID 29384802 DOI: 10.1097/Wno.0000000000000629  0.412
2018 Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. The New England Journal of Medicine. 378: 169-180. PMID 29320652 DOI: 10.1056/NEJMra1401483  0.571
2018 Calabresi PA. Advances in multiple sclerosis: from reduced relapses to remedies. The Lancet. Neurology. 17: 10-12. PMID 29262991 DOI: 10.1016/S1474-4422(17)30417-9  0.435
2017 Fritz NE, Eloyan A, Baynes M, Newsome SD, Calabresi PA, Zackowski KM. Distinguishing among multiple sclerosis fallers, near-fallers and non-fallers. Multiple Sclerosis and Related Disorders. 19: 99-104. PMID 29182996 DOI: 10.1016/J.Msard.2017.11.019  0.363
2017 Smith MD, Calabresi PA, Bhargava P. Dimethyl fumarate treatment alters NK cell function in multiple sclerosis. European Journal of Immunology. PMID 29108094 DOI: 10.1002/Eji.201747277  0.356
2017 Oh J, Bakshi R, Calabresi PA, Crainiceanu C, Henry RG, Nair G, Papinutto N, Constable RT, Reich DS, Pelletier D, Rooney W, Schwartz D, Tagge I, Shinohara RT, Simon JH, et al. The NAIMS cooperative pilot project: Design, implementation and future directions. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517739990. PMID 29106329 DOI: 10.1177/1352458517739990  0.605
2017 Bhargava P, Fitzgerald KC, Calabresi PA, Mowry EM. Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation. Jci Insight. 2. PMID 28978801 DOI: 10.1172/Jci.Insight.95302  0.375
2017 Baxi EG, DeBruin J, Jin J, Strasburger HJ, Smith MD, Orthmann-Murphy JL, Schott JT, Fairchild AN, Bergles DE, Calabresi PA. Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination. Glia. PMID 28940645 DOI: 10.1002/Glia.23229  0.371
2017 Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, Martinez-Lapiscina EH, Green AJ, Kardon R, Outteryck O, Paul F, Schippling S, Vermersch P, Villoslada P, Balk LJ, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. The Lancet. Neurology. 16: 797-812. PMID 28920886 DOI: 10.1016/S1474-4422(17)30278-8  0.376
2017 Glaister J, Carass A, NessAiver T, Stough JV, Saidha S, Calabresi PA, Prince JL. Thalamus segmentation using multi-modal feature classification: Validation and pilot study of an age-matched cohort. Neuroimage. PMID 28669906 DOI: 10.1016/J.Neuroimage.2017.06.047  0.376
2017 Shinohara RT, Oh J, Nair G, Calabresi PA, Davatzikos C, Doshi J, Henry RG, Kim G, Linn KA, Papinutto N, Pelletier D, Pham DL, Reich DS, Rooney W, Roy S, et al. Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. PMID 28642263 DOI: 10.3174/Ajnr.A5254  0.62
2017 Papinutto N, Bakshi R, Bischof A, Calabresi PA, Caverzasi E, Constable RT, Datta E, Kirkish G, Nair G, Oh J, Pelletier D, Pham DL, Reich DS, Rooney W, Roy S, et al. Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 -weighted brain MRI acquisitions. Magnetic Resonance in Medicine. PMID 28617996 DOI: 10.1002/Mrm.26776  0.507
2017 Carass A, Roy S, Jog A, Cuzzocreo JL, Magrath E, Gherman A, Button J, Nguyen J, Bazin PL, Calabresi PA, Crainiceanu CM, Ellingsen LM, Reich DS, Prince JL, Pham DL. Longitudinal multiple sclerosis lesion segmentation data resource. Data in Brief. 12: 346-350. PMID 28491937 DOI: 10.1016/J.Dib.2017.04.004  0.569
2017 Al-Louzi O, Button J, Newsome SD, Calabresi PA, Saidha S. Retrograde trans-synaptic visual pathway degeneration in multiple sclerosis: A case series. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458516679035. PMID 28385128 DOI: 10.1177/1352458516679035  0.358
2017 Fritz NE, Keller J, Calabresi PA, Zackowski KM. Quantitative measures of walking and strength provide insight into brain corticospinal tract pathology in multiple sclerosis. Neuroimage. Clinical. 14: 490-498. PMID 28289599 DOI: 10.1016/J.Nicl.2017.02.006  0.382
2017 Murphy R, O'Donoghue S, Counihan T, McDonald C, Calabresi PA, Ahmed MA, Kaplin A, Hallahan B. Neuropsychiatric syndromes of multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28285265 DOI: 10.1136/Jnnp-2016-315367  0.403
2017 Calabresi PA, van Zijl PC. Ultra-high-field (7.0 Tesla and above) MRI is now necessary to make the next step forward in understanding MS pathophysiology - Commentary. Multiple Sclerosis (Houndmills, Basingstoke, England). 23: 376-377. PMID 28260419 DOI: 10.1177/1352458516684560  0.409
2017 Arnold DL, Calabresi PA, Kieseier BC, Liu S, You X, Fiore D, Hung S. Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial. Bmc Neurology. 17: 29. PMID 28183276 DOI: 10.1186/S12883-017-0799-0  0.409
2017 Bodini B, Calabresi PA. From neurofilament research to multiple sclerosis clinical practice: Where do we stand? Neurology. 88: 816-817. PMID 28148634 DOI: 10.1212/Wnl.0000000000003676  0.425
2017 Meltzer E, Sguigna PV, Subei A, Beh S, Kildebeck E, Conger D, Conger A, Lucero M, Frohman BS, Frohman AN, Saidha S, Galetta S, Calabresi PA, Rennaker R, Frohman TC, et al. Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis. Jama Neurology. PMID 28135360 DOI: 10.1001/Jamaneurol.2016.5131  0.329
2017 Carass A, Roy S, Jog A, Cuzzocreo JL, Magrath E, Gherman A, Button J, Nguyen J, Prados F, Sudre CH, Jorge Cardoso M, Cawley N, Ciccarelli O, Wheeler-Kingshott CA, Ourselin S, ... ... Calabresi PA, et al. Longitudinal multiple sclerosis lesion segmentation: resource & challenge. Neuroimage. PMID 28087490 DOI: 10.1016/J.Neuroimage.2016.12.064  0.547
2017 Button J, Al-Louzi O, Lang A, Bhargava P, Newsome SD, Frohman T, Balcer LJ, Frohman EM, Prince J, Calabresi PA, Saidha S. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study. Neurology. PMID 28077493 DOI: 10.1212/Wnl.0000000000003582  0.39
2017 Glenn JD, Smith MD, Xue P, Chan-Li Y, Collins S, Calabresi PA, Horton MR, Whartenby KA. CNS-targeted autoimmunity leads to increased influenza mortality in mice. The Journal of Experimental Medicine. PMID 28057805 DOI: 10.1084/Jem.20160517  0.334
2016 Gordon-Lipkin E, Calabresi PA. Optical coherence tomography: A quantitative tool to measure neurodegeneration and facilitate testing of novel treatments for tissue protection in multiple sclerosis. Journal of Neuroimmunology. PMID 28038893 DOI: 10.1016/J.Jneuroim.2016.12.003  0.396
2016 Calabresi PA. B-Cell Depletion - A Frontier in Monoclonal Antibodies for Multiple Sclerosis. The New England Journal of Medicine. PMID 28001486 DOI: 10.1056/Nejme1614717  0.401
2016 Orthmann-Murphy JL, Calabresi PA. Therapeutic application of monoclonal antibodies in multiple sclerosis. Clinical Pharmacology and Therapeutics. PMID 27804128 DOI: 10.1002/Cpt.547  0.443
2016 Fritz NE, Roy S, Keller J, Prince J, Calabresi PA, Zackowski KM. Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis. Neurorehabilitation. PMID 27689612 DOI: 10.3233/Nre-161384  0.33
2016 Schiess N, Huether K, Fatafta T, Fitzgerald KC, Calabresi PA, Blair I, Alsaadi T, Szolics M. How global MS prevalence is changing: A retrospective chart review in the United Arab Emirates. Multiple Sclerosis and Related Disorders. 9: 73-9. PMID 27645349 DOI: 10.1016/J.Msard.2016.07.005  0.406
2016 Schiess N, Calabresi PA. Multiple Sclerosis. Seminars in Neurology. 36: 350-356. PMID 27643903 DOI: 10.1055/s-0036-1585456  0.32
2016 Avasarala J, Sotirchos ES, Bhargava P, Calabresi PA. Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis. Neurology. 87: 445-6. PMID 27462039 DOI: 10.1212/Wnl.0000000000002937  0.318
2016 Butzkueven H, Calabresi PA. Is my MS patient failing treatment? Neurology. PMID 27306627 DOI: 10.1212/Wnl.0000000000002851  0.394
2016 Antony BJ, Chen M, Carass A, Jedynak BM, Al-Louzi O, Solomon SD, Saidha S, Calabresi PA, Prince JL. Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings. Proceedings of Spie--the International Society For Optical Engineering. 9788. PMID 27199503 DOI: 10.1117/12.2216096  0.447
2016 Antony BJ, Lang A, Swingle EK, Al-Louzi O, Carass A, Solomon S, Calabresi PA, Saidha S, Prince JL. Simultaneous Segmentation of Retinal Surfaces and Microcystic Macular Edema in SDOCT Volumes. Proceedings of Spie--the International Society For Optical Engineering. 9784. PMID 27199502 DOI: 10.1117/12.2214676  0.384
2016 Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, ... ... Calabresi PA, et al. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. The Lancet. Neurology. PMID 27011339 DOI: 10.1016/S1474-4422(16)00068-5  0.367
2016 Petracca M, Cordano C, Cellerino M, Button J, Krieger S, Vancea R, Ghassemi R, Farrell C, Miller A, Calabresi PA, Lublin F, Inglese M. Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions? Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26993116 DOI: 10.1177/1352458516637679  0.409
2016 Schott JT, Kirby LA, Calabresi PA, Baxi EG. Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning. Journal of Visualized Experiments : Jove. PMID 26967760 DOI: 10.3791/53764  0.324
2016 Harrison DM, Li X, Liu H, Jones CK, Caffo B, Calabresi PA, van Zijl P. Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity. Ajnr. American Journal of Neuroradiology. PMID 26939635 DOI: 10.3174/Ajnr.A4726  0.426
2016 Keller JL, Fritz N, Chiang CC, Jiang A, Thompson T, Cornet N, Newsome SD, Calabresi PA, Zackowski K. Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis. Journal of Visualized Experiments : Jove. PMID 26863451 DOI: 10.3791/53449  0.313
2016 Bhargava P, Calabresi PA. Metabolomics in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26754801 DOI: 10.1177/1352458515622827  0.419
2015 Sotirchos ES, Bhargava P, Eckstein C, Van Haren K, Baynes M, Ntranos A, Gocke A, Steinman L, Mowry EM, Calabresi PA. Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis. Neurology. PMID 26718578 DOI: 10.1212/Wnl.0000000000002316  0.373
2015 Al-Louzi OA, Bhargava P, Newsome SD, Balcer LJ, Frohman EM, Crainiceanu C, Calabresi PA, Saidha S. Outer retinal changes following acute optic neuritis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26209589 DOI: 10.1177/1352458515590646  0.309
2015 Pekcevik Y, Mitchell CH, Mealy MA, Orman G, Lee IH, Newsome SD, Thompson CB, Pardo CA, Calabresi PA, Levy M, Izbudak I. Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26209588 DOI: 10.1177/1352458515591069  0.311
2015 Chahin S, Miller D, Sakai RE, Wilson JA, Frohman T, Markowitz C, Jacobs D, Green A, Calabresi PA, Frohman EM, Galetta SL, Balcer LJ. Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis. Multiple Sclerosis and Related Disorders. 4: 304-10. PMID 26195047 DOI: 10.1016/J.Msard.2015.05.005  0.417
2015 Harrison DM, Roy S, Oh J, Izbudak I, Pham D, Courtney S, Caffo B, Jones CK, van Zijl P, Calabresi PA. Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis. Jama Neurology. PMID 26192316 DOI: 10.1001/Jamaneurol.2015.1241  0.457
2015 Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD, Prince JL, Pham D, Roy S, van Zijl P, Balcer LJ, Frohman EM, Reich DS, Crainiceanu C, Calabresi PA. Optical coherence tomography reflects brain atrophy in MS: A four year study. Annals of Neurology. PMID 26190464 DOI: 10.1002/Ana.24487  0.601
2015 Grishkan IV, Tosi DM, Bowman MD, Harary M, Calabresi PA, Gocke AR. Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties. Journal of Immunology (Baltimore, Md. : 1950). PMID 26150529 DOI: 10.4049/Jimmunol.1403024  0.383
2015 Vidaurre OG, Haines JD, Sand IK, Adula KP, Huynh JL, McGraw CA, Zhang F, Varghese M, Sotirchos E, Bhargava P, Bandaru VVR, Pasinetti G, Zhang W, Inglese M, Calabresi PA, et al. Erratum: Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics (Brain (2014) 137 (2271-2286) DOI: 10.1093/brain/awu139) Brain. 138. PMID 26106099 DOI: 10.1093/Brain/Awv090  0.306
2015 Bhargava P, Lang A, Al-Louzi O, Carass A, Prince J, Calabresi PA, Saidha S. Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials. Multiple Sclerosis International. 2015: 136295. PMID 26090228 DOI: 10.1155/2015/136295  0.368
2015 Shinohara RT, Sweeney EM, Goldsmith J, Shiee N, Mateen FJ, Calabresi PA, Jarso S, Pham DL, Reich DS, Crainiceanu CM. Corrigendum to "Statistical normalization techniques for magnetic resonance imaging" [NeuroImage: Clinical 6 (2014) 9-19]. Neuroimage. Clinical. 7: 848. PMID 26082894 DOI: 10.1016/J.Nicl.2015.02.011  0.503
2015 Li X, Harrison DM, Liu H, Jones CK, Oh J, Calabresi PA, van Zijl PC. Magnetic susceptibility contrast variations in multiple sclerosis lesions. Journal of Magnetic Resonance Imaging : Jmri. PMID 26073973 DOI: 10.1002/Jmri.24976  0.438
2015 Baxi EG, DeBruin J, Tosi DM, Grishkan IV, Smith MD, Kirby LA, Strasburger HJ, Fairchild AN, Calabresi PA, Gocke AR. Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 8626-39. PMID 26041928 DOI: 10.1523/Jneurosci.3817-14.2015  0.414
2015 Mealy MA, Whetstone A, Orman G, Izbudak I, Calabresi PA, Levy M. Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. Journal of the Neurological Sciences. PMID 26026942 DOI: 10.1016/J.Jns.2015.05.013  0.422
2015 Swingle EK, Lang A, Carass A, Al-Louzi O, Saidha S, Prince JL, Calabresi PA. Segmentation of microcystic macular edema in Cirrus OCT scans with an exploratory longitudinal study. Proceedings of Spie--the International Society For Optical Engineering. 9417. PMID 26023249 DOI: 10.1117/12.2082164  0.435
2015 Jones MV, Huang H, Calabresi PA, Levy M. Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica. Acta Neuropathologica Communications. 3: 28. PMID 25990016 DOI: 10.1186/S40478-015-0207-1  0.307
2015 Absinta M, Vuolo L, Rao A, Nair G, Sati P, Cortese IC, Ohayon J, Fenton K, Reyes-Mantilla MI, Maric D, Calabresi PA, Butman JA, Pardo CA, Reich DS. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology. 85: 18-28. PMID 25888557 DOI: 10.1212/Wnl.0000000000001587  0.619
2015 Fritz NE, Newsome SD, Eloyan A, Marasigan RE, Calabresi PA, Zackowski KM. Longitudinal relationships among posturography and gait measures in multiple sclerosis. Neurology. 84: 2048-56. PMID 25878185 DOI: 10.1212/Wnl.0000000000001580  0.448
2015 Demicheva E, Cui YF, Bardwell P, Barghorn S, Kron M, Meyer AH, Schmidt M, Gerlach B, Leddy M, Barlow E, O'Connor E, Choi CH, Huang L, Veldman GM, Rus H, ... ... Calabresi PA, et al. Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosis. Cell Reports. 10: 1887-98. PMID 25801027 DOI: 10.1016/J.Celrep.2015.02.048  0.464
2015 Zackowski KM, Wang JI, McGready J, Calabresi PA, Newsome SD. Quantitative sensory and motor measures detect change overtime and correlate with walking speed in individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders. 4: 67-74. PMID 25692092 DOI: 10.1016/J.Msard.2014.11.001  0.404
2015 Bhargava P, Gocke A, Calabresi PA. 1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls. Journal of Neuroimmunology. 279: 20-4. PMID 25669995 DOI: 10.1016/J.Jneuroim.2014.12.018  0.319
2015 Lang A, Carass A, Swingle EK, Al-Louzi O, Bhargava P, Saidha S, Ying HS, Calabresi PA, Prince JL. Automatic segmentation of microcystic macular edema in OCT. Biomedical Optics Express. 6: 155-69. PMID 25657884 DOI: 10.1364/Boe.6.000155  0.387
2015 Oh J, Sotirchos ES, Saidha S, Whetstone A, Chen M, Newsome SD, Zackowski K, Balcer LJ, Frohman E, Prince J, Diener-West M, Reich DS, Calabresi PA. Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis. Neurology. 84: 720-8. PMID 25609766 DOI: 10.1212/Wnl.0000000000001257  0.593
2015 Harrison DM, Oh J, Roy S, Wood ET, Whetstone A, Seigo MA, Jones CK, Pham D, van Zijl P, Reich DS, Calabresi PA. Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25583851 DOI: 10.1177/1352458514558134  0.596
2015 Kimbrough DJ, Sotirchos ES, Wilson JA, Al-Louzi O, Conger A, Conger D, Frohman TC, Saidha S, Green AJ, Frohman EM, Balcer LJ, Calabresi PA. Retinal damage and vision loss in African American multiple sclerosis patients. Annals of Neurology. 77: 228-36. PMID 25382184 DOI: 10.1002/Ana.24308  0.411
2015 Schippling S, Balk LJ, Costello F, Albrecht P, Balcer L, Calabresi PA, Frederiksen JL, Frohman E, Green AJ, Klistorner A, Outteryck O, Paul F, Plant GT, Traber G, Vermersch P, et al. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Multiple Sclerosis (Houndmills, Basingstoke, England). 21: 163-70. PMID 24948688 DOI: 10.1177/1352458514538110  0.435
2015 Fritz NE, Marasigan RE, Calabresi PA, Newsome SD, Zackowski KM. The impact of dynamic balance measures on walking performance in multiple sclerosis. Neurorehabilitation and Neural Repair. 29: 62-9. PMID 24795162 DOI: 10.1177/1545968314532835  0.403
2014 Arnold DL, Calabresi PA, Kieseier BC, Sheikh SI, Deykin A, Zhu Y, Liu S, You X, Sperling B, Hung S. Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis. Bmc Neurology. 14: 240. PMID 25551571 DOI: 10.1186/S12883-014-0240-X  0.348
2014 Hemmer B, Calabresi PA. Complex antibody profiling to predict clinical outcome in childhood ADS. Neurology. 83: 2200-1. PMID 25381297 DOI: 10.1212/Wnl.0000000000001083  0.337
2014 Shinohara RT, Sweeney EM, Goldsmith J, Shiee N, Mateen FJ, Calabresi PA, Jarso S, Pham DL, Reich DS, Crainiceanu CM. Statistical normalization techniques for magnetic resonance imaging. Neuroimage. Clinical. 6: 9-19. PMID 25379412 DOI: 10.1016/J.Nicl.2014.08.008  0.541
2014 Eloyan A, Shou H, Shinohara RT, Sweeney EM, Nebel MB, Cuzzocreo JL, Calabresi PA, Reich DS, Lindquist MA, Crainiceanu CM. Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment. Plos One. 9: e107263. PMID 25233361 DOI: 10.1371/Journal.Pone.0107263  0.567
2014 Saidha S, Calabresi PA. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: yes. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1296-8. PMID 25160122 DOI: 10.1177/1352458514541509  0.366
2014 Seddighzadeh A, Hung S, Selmaj K, Cui Y, Liu S, Sperling B, Calabresi PA. Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study. Expert Opinion On Drug Delivery. 11: 1713-20. PMID 25073663 DOI: 10.1517/17425247.2014.944159  0.369
2014 Chen M, Lang A, Ying HS, Calabresi PA, Prince JL, Carass A. Analysis of macular OCT images using deformable registration. Biomedical Optics Express. 5: 2196-214. PMID 25071959 DOI: 10.1364/Boe.5.002196  0.376
2014 Glenn JD, Smith MD, Calabresi PA, Whartenby KA. Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis. Stem Cells (Dayton, Ohio). 32: 2744-55. PMID 24911892 DOI: 10.1002/Stem.1755  0.307
2014 Vidaurre OG, Haines JD, Katz Sand I, Adula KP, Huynh JL, McGraw CA, Zhang F, Varghese M, Sotirchos E, Bhargava P, Bandaru VV, Pasinetti G, Zhang W, Inglese M, Calabresi PA, et al. Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain : a Journal of Neurology. 137: 2271-86. PMID 24893707 DOI: 10.1093/Brain/Awu139  0.323
2014 Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 83: 278-86. PMID 24871874 DOI: 10.1212/Wnl.0000000000000560  0.427
2014 Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A. Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. The Lancet. Neurology. 13: 657-65. PMID 24794721 DOI: 10.1016/S1474-4422(14)70068-7  0.3
2014 Schnurman ZS, Frohman TC, Beh SC, Conger D, Conger A, Saidha S, Galetta S, Calabresi PA, Green AJ, Balcer LJ, Frohman EM. Retinal architecture and mfERG: Optic nerve head component response characteristics in MS. Neurology. 82: 1888-96. PMID 24789865 DOI: 10.1212/Wnl.0000000000000447  0.396
2014 Sweeney EM, Vogelstein JT, Cuzzocreo JL, Calabresi PA, Reich DS, Crainiceanu CM, Shinohara RT. A comparison of supervised machine learning algorithms and feature vectors for MS lesion segmentation using multimodal structural MRI. Plos One. 9: e95753. PMID 24781953 DOI: 10.1371/Journal.Pone.0095753  0.567
2014 Carass A, Lang A, Hauser M, Calabresi PA, Ying HS, Prince JL. Multiple-object geometric deformable model for segmentation of macular OCT. Biomedical Optics Express. 5: 1062-74. PMID 24761289 DOI: 10.1364/Boe.5.001062  0.326
2014 Calabresi PA, Radue EW, Goodin D, Jeffery D, Rammohan KW, Reder AT, Vollmer T, Agius MA, Kappos L, Stites T, Li B, Cappiello L, von Rosenstiel P, Lublin FD. Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet. Neurology. 13: 545-56. PMID 24685276 DOI: 10.1016/S1474-4422(14)70049-3  0.32
2014 Oh J, Seigo M, Saidha S, Sotirchos E, Zackowski K, Chen M, Prince J, Diener-West M, Calabresi PA, Reich DS. Spinal cord normalization in multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 24: 577-84. PMID 24593281 DOI: 10.1111/Jon.12097  0.588
2014 Oh J, Saidha S, Cortese I, Ohayon J, Bielekova B, Calabresi PA, Newsome SD. Daclizumab-induced adverse events in multiple organ systems in multiple sclerosis. Neurology. 82: 984-8. PMID 24532277 DOI: 10.1212/Wnl.0000000000000222  0.399
2014 Shiee N, Bazin PL, Cuzzocreo JL, Ye C, Kishore B, Carass A, Calabresi PA, Reich DS, Prince JL, Pham DL. Reconstruction of the human cerebral cortex robust to white matter lesions: method and validation. Human Brain Mapping. 35: 3385-401. PMID 24382742 DOI: 10.1002/Hbm.22409  0.565
2014 Swingle EK, Lang A, Carass A, Ying HS, Calabresi PA, Prince JL. Microcystic macular edema detection in retina OCT images Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9038. DOI: 10.1117/12.2043910  0.411
2013 Roy S, Carass A, Shiee N, Pham DL, Calabresi P, Reich D, Prince JL. LONGITUDINAL INTENSITY NORMALIZATION IN THE PRESENCE OF MULTIPLE SCLEROSIS LESIONS. Proceedings / Ieee International Symposium On Biomedical Imaging: From Nano to Macro. Ieee International Symposium On Biomedical Imaging. 1384-1387. PMID 24816891 DOI: 10.1109/ISBI.2013.6556791  0.531
2013 Waldman AT, Hiremath G, Avery RA, Conger A, Pineles SL, Loguidice MJ, Talman LS, Galetta KM, Shumski MJ, Wilson J, Ford E, Lavery AM, Conger D, Greenberg BM, Ellenberg JH, ... ... Calabresi PA, et al. Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis. Multiple Sclerosis and Related Disorders. 3: 326-334. PMID 24683535 DOI: 10.1016/J.Msard.2013.10.008  0.41
2013 Grishkan IV, Fairchild AN, Calabresi PA, Gocke AR. 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization. Proceedings of the National Academy of Sciences of the United States of America. 110: 21101-6. PMID 24324134 DOI: 10.1073/Pnas.1306072110  0.333
2013 Chen M, Carass A, Reich DS, Calabresi PA, Pham D, Prince JL. Voxel-Wise Displacement as Independent Features in Classification of Multiple Sclerosis. Proceedings of Spie--the International Society For Optical Engineering. 8669. PMID 24236227 DOI: 10.1117/12.2007150  0.588
2013 Sweeney EM, Shinohara RT, Shiee N, Mateen FJ, Chudgar AA, Cuzzocreo JL, Calabresi PA, Pham DL, Reich DS, Crainiceanu CM. OASIS is Automated Statistical Inference for Segmentation, with applications to multiple sclerosis lesion segmentation in MRI. Neuroimage. Clinical. 2: 402-13. PMID 24179794 DOI: 10.1016/J.Nicl.2013.03.002  0.611
2013 Oh J, Calabresi PA. Emerging injectable therapies for multiple sclerosis. The Lancet. Neurology. 12: 1115-26. PMID 24090587 DOI: 10.1016/S1474-4422(13)70192-3  0.342
2013 Winges KM, Werner JS, Harvey DJ, Cello KE, Durbin MK, Balcer LJ, Calabresi PA, Keltner JL. Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 33: 322-9. PMID 24051419 DOI: 10.1097/Wno.0B013E31829C51F7  0.407
2013 Ratchford JN, Costello K, Reich DS, Calabresi PA. Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. Neurology. 81: 306. PMID 24024233 DOI: 10.1212/01.Wnl.0000432547.27815.74  0.572
2013 Abrahamsson SV, Angelini DF, Dubinsky AN, Morel E, Oh U, Jones JL, Carassiti D, Reynolds R, Salvetti M, Calabresi PA, Coles AJ, Battistini L, Martin R, Burt RK, Muraro PA. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Brain : a Journal of Neurology. 136: 2888-903. PMID 23864273 DOI: 10.1093/Brain/Awt182  0.326
2013 Lang A, Carass A, Hauser M, Sotirchos ES, Calabresi PA, Ying HS, Prince JL. Retinal layer segmentation of macular OCT images using boundary classification. Biomedical Optics Express. 4: 1133-52. PMID 23847738 DOI: 10.1364/Boe.4.001133  0.331
2013 Aquino JJ, Sotirchos ES, Saidha S, Raymond GV, Calabresi PA. Optical coherence tomography in x-linked adrenoleukodystrophy. Pediatric Neurology. 49: 182-4. PMID 23838412 DOI: 10.1016/J.Pediatrneurol.2013.04.012  0.326
2013 Frohman TC, Beh SC, Saidha S, Schnurman Z, Conger D, Conger A, Ratchford JN, Lopez C, Galetta SL, Calabresi PA, Balcer LJ, Green AJ, Frohman EM. Optic nerve head component responses of the multifocal electroretinogram in MS. Neurology. 81: 545-51. PMID 23825172 DOI: 10.1212/Wnl.0B013E31829E6Faa  0.42
2013 Johnson TP, Tyagi R, Patel K, Schiess N, Calabresi PA, Nath A. Impaired toll-like receptor 8 signaling in multiple sclerosis. Journal of Neuroinflammation. 10: 74. PMID 23787171 DOI: 10.1186/1742-2094-10-74  0.428
2013 Roth NM, Saidha S, Zimmermann H, Brandt AU, Oberwahrenbrock T, Maragakis NJ, Tumani H, Ludolph AC, Meyer T, Calabresi PA, Paul F. Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 1170-6. PMID 23582075 DOI: 10.1111/Ene.12146  0.345
2013 Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, Lisak R, Miller A, Racke MK, Steinman L, Stuve O, et al. Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. Jama Neurology. 70: 248-51. PMID 23530268 DOI: 10.1001/Jamaneurol.2013.1017  0.347
2013 Syc SB, Harrison DM, Saidha S, Seigo M, Calabresi PA, Reich DS. Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis. Multiple Sclerosis International. 2013: 838719. PMID 23476776 DOI: 10.1155/2013/838719  0.608
2013 Oh J, Saidha S, Chen M, Smith SA, Prince J, Jones C, Diener-West M, van Zijl PC, Reich DS, Calabresi PA. Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis. Neurology. 80: 540-7. PMID 23325903 DOI: 10.1212/Wnl.0B013E31828154C5  0.622
2013 Saidha S, Sotirchos ES, Oh J, Syc SB, Seigo MA, Shiee N, Eckstein C, Durbin MK, Oakley JD, Meyer SA, Frohman TC, Newsome S, Ratchford JN, Balcer LJ, Pham DL, ... ... Calabresi PA, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. Jama Neurology. 70: 34-43. PMID 23318513 DOI: 10.1001/Jamaneurol.2013.573  0.613
2013 Oh J, Sotirchos ES, Saidha S, Ibrahim M, Sepah Y, Nguyen QD, Calabresi PA. In vivo demonstration of homonymous hemimacular loss of retinal ganglion cells due to a thalamic lesion using optical coherence tomography. Jama Neurology. 70: 410-1. PMID 23303271 DOI: 10.1001/Jamaneurol.2013.605  0.32
2013 Ratchford JN, Saidha S, Sotirchos ES, Oh JA, Seigo MA, Eckstein C, Durbin MK, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome SD, Balcer LJ, Frohman EM, Calabresi PA. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology. 80: 47-54. PMID 23267030 DOI: 10.1212/Wnl.0B013E31827B1A1C  0.473
2013 Ozturk A, Aygun N, Smith SA, Caffo B, Calabresi PA, Reich DS. Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T. Neuroradiology. 55: 431-9. PMID 23208410 DOI: 10.1007/S00234-012-1118-5  0.595
2013 Sotirchos ES, Seigo MA, Calabresi PA, Saidha S. Comparison of point estimates and average thicknesses of retinal layers measured using manual optical coherence tomography segmentation for quantification of retinal neurodegeneration in multiple sclerosis. Current Eye Research. 38: 224-8. PMID 22954302 DOI: 10.3109/02713683.2012.722243  0.358
2013 Oh J, Zackowski K, Chen M, Newsome S, Saidha S, Smith SA, Diener-West M, Prince J, Jones CK, Van Zijl PC, Calabresi PA, Reich DS. Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 427-35. PMID 22891033 DOI: 10.1177/1352458512456614  0.642
2013 Harrison DM, Shiee N, Bazin PL, Newsome SD, Ratchford JN, Pham D, Calabresi PA, Reich DS. Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis. Journal of Neurology. 260: 397-406. PMID 22886062 DOI: 10.1007/S00415-012-6638-8  0.639
2013 He Q, Shiee N, Reich DS, Calabresi PA, Pham DL. Intensity standardization of longitudinal images using 4D clustering Proceedings - International Symposium On Biomedical Imaging. 1388-1391. DOI: 10.1109/ISBI.2013.6556792  0.408
2013 Roy S, Carass A, Shiee N, Pham DL, Calabresi P, Reich D, Prince JL. Longitudinal intensity normalization in the presence of multiple sclerosis lesions Proceedings - International Symposium On Biomedical Imaging. 1384-1387. DOI: 10.1109/ISBI.2013.6556791  0.527
2012 Rahn KA, Watkins CC, Alt J, Rais R, Stathis M, Grishkan I, Crainiceau CM, Pomper MG, Rojas C, Pletnikov MV, Calabresi PA, Brandt J, Barker PB, Slusher BS, Kaplin AI. Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 109: 20101-6. PMID 23169655 DOI: 10.1073/Pnas.1209934109  0.366
2012 von Geldern G, Pardo CA, Calabresi PA, Newsome SD. PML-IRIS in a patient treated with brentuximab. Neurology. 79: 2075-7. PMID 23115213 DOI: 10.1212/Wnl.0B013E3182749F17  0.316
2012 Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. The Lancet. Neurology. 11: 963-72. PMID 23041237 DOI: 10.1016/S1474-4422(12)70213-2  0.459
2012 Ratchford JN, Costello K, Reich DS, Calabresi PA. Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. Neurology. 79: 2002-4. PMID 23035072 DOI: 10.1212/Wnl.0B013E3182735D00  0.552
2012 Blazek P, Davis SL, Greenberg BM, Conger A, Conger D, Vernino S, Beh S, Stuve O, Saidha S, Ratchford JN, Green A, Calabresi PA, Balcer LJ, Frohman TC, Frohman EM. Objective characterization of the relative afferent pupillary defect in MS. Journal of the Neurological Sciences. 323: 193-200. PMID 23026533 DOI: 10.1016/J.Jns.2012.09.015  0.372
2012 Jia Y, Wu T, Jelinek CA, Bielekova B, Chang L, Newsome S, Gnanapavan S, Giovannoni G, Chen D, Calabresi PA, Nath A, Cotter RJ. Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS). Clinical Proteomics. 9: 9. PMID 22846148 DOI: 10.1186/1559-0275-9-9  0.377
2012 Frohman AR, Schnurman Z, Conger A, Conger D, Beh S, Greenberg B, Sutter E, Calabresi PA, Balcer LJ, Frohman TC, Frohman EM. Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS. Neurology. 79: 797-801. PMID 22815550 DOI: 10.1212/Wnl.0B013E3182661Edc  0.412
2012 Calabresi PA, Bohnen NI. Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis? Neurology. 79: 496-7. PMID 22764259 DOI: 10.1212/Wnl.0B013E3182635824  0.313
2012 Radue EW, O'Connor P, Polman CH, Hohlfeld R, Calabresi P, Selmaj K, Mueller-Lenke N, Agoropoulou C, Holdbrook F, de Vera A, Zhang-Auberson L, Francis G, Burtin P, Kappos L. Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis. Archives of Neurology. 69: 1259-69. PMID 22751847 DOI: 10.1001/Archneurol.2012.1051  0.429
2012 Shiee N, Bazin PL, Zackowski KM, Farrell SK, Harrison DM, Newsome SD, Ratchford JN, Caffo BS, Calabresi PA, Pham DL, Reich DS. Revisiting brain atrophy and its relationship to disability in multiple sclerosis. Plos One. 7: e37049. PMID 22615886 DOI: 10.1371/Journal.Pone.0037049  0.623
2012 Wood ET, Ronen I, Techawiboonwong A, Jones CK, Barker PB, Calabresi P, Harrison D, Reich DS. Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 6665-9. PMID 22573688 DOI: 10.1523/Jneurosci.0044-12.2012  0.597
2012 Balcer LJ, Galetta SL, Polman CH, Eggenberger E, Calabresi PA, Zhang A, Scanlon JV, Hyde R. Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS. Journal of the Neurological Sciences. 318: 119-24. PMID 22521274 DOI: 10.1016/J.Jns.2012.03.009  0.352
2012 Seigo MA, Sotirchos ES, Newsome S, Babiarz A, Eckstein C, Ford E, Oakley JD, Syc SB, Frohman TC, Ratchford JN, Balcer LJ, Frohman EM, Calabresi PA, Saidha S. In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. Journal of Neurology. 259: 2119-30. PMID 22418995 DOI: 10.1007/S00415-012-6466-X  0.392
2012 Walter SD, Ishikawa H, Galetta KM, Sakai RE, Feller DJ, Henderson SB, Wilson JA, Maguire MG, Galetta SL, Frohman E, Calabresi PA, Schuman JS, Balcer LJ. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology. 119: 1250-7. PMID 22365058 DOI: 10.1016/J.Ophtha.2011.11.032  0.409
2012 Galetta KM, Graves J, Talman LS, Lile DJ, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ. Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 32: 116-23. PMID 22269944 DOI: 10.1097/Wno.0B013E318240204D  0.446
2012 Saidha S, Eckstein C, Calabresi PA. New and emerging disease modifying therapies for multiple sclerosis. Annals of the New York Academy of Sciences. 1247: 117-37. PMID 22224673 DOI: 10.1111/J.1749-6632.2011.06272.X  0.409
2012 Eckstein C, Saidha S, Sotirchos ES, Byraiah G, Seigo M, Stankiewicz A, Syc SB, Ford E, Sharma S, Calabresi PA, Pardo CA. Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with optical coherence tomography. Journal of Neurology. 259: 1390-8. PMID 22215236 DOI: 10.1007/S00415-011-6363-8  0.354
2012 Kieseier BC, Calabresi PA. PEGylation of interferon-β-1a: a promising strategy in multiple sclerosis. Cns Drugs. 26: 205-14. PMID 22201341 DOI: 10.2165/11596970-000000000-00000  0.319
2012 Ratchford JN, Endres CJ, Hammoud DA, Pomper MG, Shiee N, McGready J, Pham DL, Calabresi PA. Decreased microglial activation in MS patients treated with glatiramer acetate. Journal of Neurology. 259: 1199-205. PMID 22160466 DOI: 10.1007/S00415-011-6337-X  0.395
2012 Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, Crainiceanu CM, Durbin MK, Oakley JD, Meyer SA, Frohman EM, Calabresi PA. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain : a Journal of Neurology. 135: 521-33. PMID 22006982 DOI: 10.1093/Brain/Awr264  0.349
2012 Zhang J, Jones MV, McMahon MT, Mori S, Calabresi PA. In vivo and ex vivo diffusion tensor imaging of cuprizone-induced demyelination in the mouse corpus callosum. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 67: 750-9. PMID 21656567 DOI: 10.1002/Mrm.23032  0.323
2012 Conger A, Conger D, Frohman T, Beh S, Greenberg B, Balcer L, Calabresi P, Frohman E. Assessment of Multiple Sclerosis Patients with a Known History of Unilateral Optic Neuritis Shows Optic Nerve Head Component Loss in the Fellow Unaffected Eye (S58.004) Neurology. 78: S58.004-S58.004. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S58.004  0.344
2012 Davies E, Ishikawa H, Galetta K, Sakai R, Feller D, Wilson J, Maguire M, Galetta S, Frohman E, Calabresi P, Schuman J, Balcer L. Longitudinal Study of Retinal Ganglion Cell Layer Thickness by OCT in Multiple Sclerosis (S48.003) Neurology. 78: S48.003-S48.003. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S48.003  0.339
2012 Kappos L, Radue E, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Jin J, Zhang-Auberson L, Francis G. Long-Term Efficacy and Safety of Fingolimod (FTY720) in Relapsing-Remitting Multiple Sclerosis (RRMS): Results from the Extension of the Phase III FREEDOMS Study (S41.004) Neurology. 78: S41.004-S41.004. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S41.004  0.321
2012 Hauser S, Kappos L, Li D, Calabresi P, O'Connor P, Bar-Or A, Barkhof F, Wells C, Leppert D, Glanzman R, Tinbergen J. Long-Term Efficacy and Safety of Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Week 96 Results of a Phase II, Randomized, Multicenter Trial (S30.006) Neurology. 78: S30.006-S30.006. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S30.006  0.34
2012 Oh J, Zackowski K, Chen M, Newsome S, Smith S, Prince J, Calabresi P, Reich D. Diffusion Tensor and Magnetization Transfer Imaging Correlates of Motor Dysfunction in the Spinal Cord in Multiple Sclerosis (S21.002) Neurology. 78: S21.002-S21.002. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S21.002  0.328
2012 Sotirchos E, Seigo M, Babiarz A, Eckstein C, Syc S, Ford E, Newsome S, Ratchford J, Balcer L, Frohman E, Calabresi P, Saidha S. In-Vivo Assessment of Retinal Neuronal Layers in Multiple Sclerosis with Manual and Automated Optical Coherence Tomography Segmentation Techniques (S10.003) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S10.003  0.336
2012 Conger D, Conger A, Frohman T, Balcer L, Calabresi P, Beh S, Greenberg B, Frohman E. Deriving Clinically Useful Visual Evoked Potential Measurements from 120 Sector Multi-Focal Visual Evoked Potential Sequences (P07.259) Neurology. 78: P07.259-P07.259. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.259  0.312
2012 Harrison D, Oh J, Jones C, Hua J, Wood E, Calabresi P, Van Zijl P, Reich D. A Method for Analysis of Cortical Lesions on 7-Tesla MRI in Multiple Sclerosis (P03.064) Neurology. 78: P03.064-P03.064. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.064  0.575
2011 Calabresi PA. Inflammation in multiple sclerosis--sorting out the gray matter. The New England Journal of Medicine. 365: 2231-3. PMID 22150043 DOI: 10.1056/Nejme1111945  0.426
2011 Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1449-63. PMID 21865411 DOI: 10.1177/1352458511418630  0.435
2011 Warner CV, Syc SB, Stankiewicz AM, Hiremath G, Farrell SK, Crainiceanu CM, Conger A, Frohman TC, Bisker ER, Balcer LJ, Frohman EM, Calabresi PA, Saidha S. The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. Plos One. 6: e22947. PMID 21853058 DOI: 10.1371/Journal.Pone.0022947  0.377
2011 Smith SA, Williams ZR, Ratchford JN, Newsome SD, Farrell SK, Farrell JA, Gifford A, Miller NR, van Zijl PC, Calabresi PA, Reich DS. Diffusion tensor imaging of the optic nerve in multiple sclerosis: association with retinal damage and visual disability. Ajnr. American Journal of Neuroradiology. 32: 1662-8. PMID 21799043 DOI: 10.3174/Ajnr.A2574  0.496
2011 Davies EC, Galetta KM, Sackel DJ, Talman LS, Frohman EM, Calabresi PA, Galetta SL, Balcer LJ. Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 31: 260-4. PMID 21654523 DOI: 10.1097/Wno.0B013E318221B434  0.413
2011 Pineles SL, Birch EE, Talman LS, Sackel DJ, Frohman EM, Calabresi PA, Galetta SL, Maguire MG, Balcer LJ. One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. American Journal of Ophthalmology. 152: 133-40. PMID 21570055 DOI: 10.1016/J.Ajo.2011.01.023  0.37
2011 Newsome SD, Wang JI, Kang JY, Calabresi PA, Zackowski KM. Quantitative measures detect sensory and motor impairments in multiple sclerosis. Journal of the Neurological Sciences. 305: 103-11. PMID 21458828 DOI: 10.1016/J.Jns.2011.03.003  0.427
2011 Galetta KM, Calabresi PA, Frohman EM, Balcer LJ. Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 8: 117-32. PMID 21274691 DOI: 10.1007/S13311-010-0005-1  0.422
2011 Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, Oakley JD, Durbin MK, Meyer SA, Balcer LJ, Frohman EM, Rosenzweig JM, Newsome SD, Ratchford JN, Nguyen QD, ... Calabresi PA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain : a Journal of Neurology. 134: 518-33. PMID 21252110 DOI: 10.1093/Brain/Awq346  0.408
2011 Syc SB, Warner CV, Saidha S, Farrell SK, Conger A, Bisker ER, Wilson J, Frohman TC, Frohman EM, Balcer LJ, Calabresi PA. Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis. Journal of the Neurological Sciences. 302: 19-24. PMID 21227470 DOI: 10.1016/j.jns.2010.12.011  0.325
2011 Harrison DM, Caffo BS, Shiee N, Farrell JA, Bazin PL, Farrell SK, Ratchford JN, Calabresi PA, Reich DS. Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis. Neurology. 76: 179-86. PMID 21220722 DOI: 10.1212/Wnl.0B013E318206Ca61  0.534
2011 Dasenbrock HH, Smith SA, Ozturk A, Farrell SK, Calabresi PA, Reich DS. Diffusion tensor imaging of the optic tracts in multiple sclerosis: association with retinal thinning and visual disability. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 21: e41-9. PMID 20331501 DOI: 10.1111/J.1552-6569.2010.00468.X  0.579
2011 Shiee N, Bazin PL, Calabresi PA, Reich DS, Pham DL. Fiber tractogrophy and tract segmentation in multiple sclerosis lesions Proceedings - International Symposium On Biomedical Imaging. 1488-1491. DOI: 10.1109/ISBI.2011.5872682  0.495
2011 Nath A, Calabresi PA. Neuroprotection in multiple sclerosis Multiple Sclerosis Therapeutics, Fourth Edition. 535-546. DOI: 10.1017/CBO9781139023986.049  0.335
2010 Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. The Lancet. Neurology. 9: 921-32. PMID 20723847 DOI: 10.1016/S1474-4422(10)70168-X  0.429
2010 DeBoy CA, Rus H, Tegla C, Cudrici C, Jones MV, Pardo CA, Small D, Whartenby KA, Calabresi PA. FLT-3 expression and function on microglia in multiple sclerosis. Experimental and Molecular Pathology. 89: 109-16. PMID 20566414 DOI: 10.1016/J.Yexmp.2010.05.009  0.41
2010 Syc SB, Warner CV, Hiremath GS, Farrell SK, Ratchford JN, Conger A, Frohman T, Cutter G, Balcer LJ, Frohman EM, Calabresi PA. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 829-39. PMID 20530512 DOI: 10.1177/1352458510371640  0.443
2010 Talman LS, Bisker ER, Sackel DJ, Long DA, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, ... ... Calabresi PA, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Annals of Neurology. 67: 749-60. PMID 20517936 DOI: 10.1002/Ana.22005  0.389
2010 Calabresi PA, Balcer LJ, Frohman EM. Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology. Brain : a Journal of Neurology. 133: 1575-7. PMID 20511281 DOI: 10.1093/Brain/Awq133  0.307
2010 Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, Calabresi PA, Waubant E, Hauser SL, Zhang J, Smith CH. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Annals of Neurology. 67: 452-61. PMID 20437580 DOI: 10.1002/Ana.21939  0.393
2010 Farrell JA, Zhang J, Jones MV, Deboy CA, Hoffman PN, Landman BA, Smith SA, Reich DS, Calabresi PA, van Zijl PC. q-space and conventional diffusion imaging of axon and myelin damage in the rat spinal cord after axotomy. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 63: 1323-35. PMID 20432303 DOI: 10.1002/Mrm.22389  0.521
2010 Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW. Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis. Journal of the Neurological Sciences. 292: 28-35. PMID 20236661 DOI: 10.1016/J.Jns.2010.02.012  0.379
2010 Frohman EM, Balcer LJ, Calabresi PA. Multiple sclerosis: can retinal imaging accurately detect optic neuritis? Nature Reviews. Neurology. 6: 125-6. PMID 20212426 DOI: 10.1038/Nrneurol.2010.13  0.355
2010 Ozturk A, Smith SA, Gordon-Lipkin EM, Harrison DM, Shiee N, Pham DL, Caffo BS, Calabresi PA, Reich DS. MRI of the corpus callosum in multiple sclerosis: association with disability. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 166-77. PMID 20142309 DOI: 10.1177/1352458509353649  0.618
2010 Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. The New England Journal of Medicine. 362: 387-401. PMID 20089952 DOI: 10.1056/Nejmoa0909494  0.348
2010 Reich DS, Ozturk A, Calabresi PA, Mori S. Automated vs. conventional tractography in multiple sclerosis: variability and correlation with disability. Neuroimage. 49: 3047-56. PMID 19944769 DOI: 10.1016/J.Neuroimage.2009.11.043  0.592
2010 Smith SA, Jones CK, Gifford A, Belegu V, Chodkowski B, Farrell JA, Landman BA, Reich DS, Calabresi PA, McDonald JW, van Zijl PC. Reproducibility of tract-specific magnetization transfer and diffusion tensor imaging in the cervical spinal cord at 3 tesla. Nmr in Biomedicine. 23: 207-17. PMID 19924726 DOI: 10.1002/Nbm.1447  0.565
2010 Shiee N, Bazin PL, Ozturk A, Reich DS, Calabresi PA, Pham DL. A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. Neuroimage. 49: 1524-35. PMID 19766196 DOI: 10.1016/J.Neuroimage.2009.09.005  0.586
2010 Landman BA, Farrell JA, Smith SA, Reich DS, Calabresi PA, van Zijl PC. Complex geometric models of diffusion and relaxation in healthy and damaged white matter. Nmr in Biomedicine. 23: 152-62. PMID 19739233 DOI: 10.1002/Nbm.1437  0.507
2010 Balcer LJ, Frohman EM, Calabresi PA, Galetta SL. Evaluating retinal abnormalities in patients with multiple sclerosis - Reply Archives of Neurology. 67: 1035-1036. DOI: 10.1001/Archneurol.2010.181  0.392
2009 Harrison DM, Calabresi PA. Promising treatments of tomorrow for multiple sclerosis. Annals of Indian Academy of Neurology. 12: 283-90. PMID 20182576 DOI: 10.4103/0972-2327.58279  0.307
2009 Burkholder BM, Osborne B, Loguidice MJ, Bisker E, Frohman TC, Conger A, Ratchford JN, Warner C, Markowitz CE, Jacobs DA, Galetta SL, Cutter GR, Maguire MG, Calabresi PA, Balcer LJ, et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Archives of Neurology. 66: 1366-72. PMID 19901168 DOI: 10.1001/Archneurol.2009.230  0.433
2009 Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Annals of Neurology. 66: 460-71. PMID 19847908 DOI: 10.1002/Ana.21867  0.399
2009 Reich DS, Smith SA, Gordon-Lipkin EM, Ozturk A, Caffo BS, Balcer LJ, Calabresi PA. Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Archives of Neurology. 66: 998-1006. PMID 19667222 DOI: 10.1001/Archneurol.2009.107  0.605
2009 Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 73: 302-8. PMID 19636050 DOI: 10.1212/Wnl.0B013E3181Af78B8  0.392
2009 Barkhof F, Calabresi PA, Miller DH, Reingold SC. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nature Reviews. Neurology. 5: 256-66. PMID 19488083 DOI: 10.1038/Nrneurol.2009.41  0.439
2009 Frohman EM, Dwyer MG, Frohman T, Cox JL, Salter A, Greenberg BM, Hussein S, Conger A, Calabresi P, Balcer LJ, Zivadinov R. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. Journal of the Neurological Sciences. 282: 96-105. PMID 19439327 DOI: 10.1016/J.Jns.2009.04.010  0.351
2009 Hiremath GS, Cettomai D, Baynes M, Ratchford JN, Newsome S, Harrison D, Kerr D, Greenberg BM, Calabresi PA. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 735-40. PMID 19383644 DOI: 10.1177/1352458509102844  0.341
2009 Hutchinson M, Kappos L, Calabresi PA, Confavreux C, Giovannoni G, Galetta SL, Havrdova E, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, et al. The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. Journal of Neurology. 256: 405-15. PMID 19308305 DOI: 10.1007/S00415-009-0093-1  0.41
2009 Skarica M, Wang T, McCadden E, Kardian D, Calabresi PA, Small D, Whartenby KA. Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 182: 4192-9. PMID 19299717 DOI: 10.4049/Jimmunol.0803631  0.302
2009 Zackowski KM, Smith SA, Reich DS, Gordon-Lipkin E, Chodkowski BA, Sambandan DR, Shteyman M, Bastian AJ, van Zijl PC, Calabresi PA. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord. Brain : a Journal of Neurology. 132: 1200-9. PMID 19297508 DOI: 10.1093/Brain/Awp032  0.56
2009 Zhang J, Jones M, DeBoy CA, Reich DS, Farrell JA, Hoffman PN, Griffin JW, Sheikh KA, Miller MI, Mori S, Calabresi PA. Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 3160-71. PMID 19279253 DOI: 10.1523/Jneurosci.3941-08.2009  0.533
2009 Schiess N, Calabresi PA. Natalizumab: bound to rebound? Neurology. 72: 392-3. PMID 19188569 DOI: 10.1212/01.Wnl.0000341783.33962.5B  0.317
2009 Hutchinson M, Kappos L, Calabresi PA, Confavreux C, Giovannoni G, Galetta SL, Havrdova E, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, et al. Erratum: The efficacy of natalizumab in patients with relapsing multiple sclerosis: Subgroup analyses of AFFIRM and SENTINEL (Journal of Neurology (2009) 256 (405-415) DOI: 10.1007/s00415-009-0093-1) Journal of Neurology. 256: 1035-1037. DOI: 10.1007/S00415-009-5183-6  0.37
2008 Salter AR, Conger A, Frohman TC, Zivadinov R, Eggenberger E, Calabresi P, Cutter G, Balcer L, Frohman EM. Retinal architecture predicts pupillary reflex metrics in MS. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 479-86. PMID 19091882 DOI: 10.1177/1352458508100503  0.402
2008 Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nature Clinical Practice. Neurology. 4: 664-75. PMID 19043423 DOI: 10.1038/Ncpneuro0950  0.434
2008 Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA. Reproducibility of optical coherence tomography in multiple sclerosis. Archives of Neurology. 65: 1218-22. PMID 18779426 DOI: 10.1001/Archneur.65.9.1218  0.458
2008 Wheeler D, Bandaru VV, Calabresi PA, Nath A, Haughey NJ. A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain : a Journal of Neurology. 131: 3092-102. PMID 18772223 DOI: 10.1093/Brain/Awn190  0.321
2008 Zaveri MS, Conger A, Salter A, Frohman TC, Galetta SL, Markowitz CE, Jacobs DA, Cutter GR, Ying GS, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Archives of Neurology. 65: 924-8. PMID 18625859 DOI: 10.1001/Archneur.65.7.924  0.422
2008 Jones MV, Nguyen TT, Deboy CA, Griffin JW, Whartenby KA, Kerr DA, Calabresi PA. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 199: 83-93. PMID 18582952 DOI: 10.1016/J.Jneuroim.2008.05.013  0.356
2008 Krishnan C, Kaplin AI, Brodsky RA, Drachman DB, Jones RJ, Pham DL, Richert ND, Pardo CA, Yousem DM, Hammond E, Quigg M, Trecker C, McArthur JC, Nath A, Greenberg BM, ... Calabresi PA, et al. Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis. Archives of Neurology. 65: 1044-51. PMID 18541787 DOI: 10.1001/Archneurol.65.8.Noc80042  0.418
2008 Farrell JA, Smith SA, Gordon-Lipkin EM, Reich DS, Calabresi PA, van Zijl PC. High b-value q-space diffusion-weighted MRI of the human cervical spinal cord in vivo: feasibility and application to multiple sclerosis. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 59: 1079-89. PMID 18429023 DOI: 10.1002/Mrm.21563  0.536
2008 Ratchford JN, Calabresi PA. The diagnosis of MS: white spots and red flags. Neurology. 70: 1071-2. PMID 18362269 DOI: 10.1212/01.Wnl.0000307667.44679.32  0.455
2008 Greenberg BM, Calabresi PA. Future research directions in multiple sclerosis therapies. Seminars in Neurology. 28: 121-7. PMID 18256992 DOI: 10.1055/S-2007-1019133  0.4
2008 Cohen JA, Calabresi PA, Chakraborty S, Edwards KR, Eickenhorst T, Felton WL, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Imrey PB, Ivancic DM, Mandell BF, Perryman JE, et al. Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 370-82. PMID 18208877 DOI: 10.1177/1352458507083189  0.397
2008 Frohman EM, Costello F, Stüve O, Calabresi P, Miller DH, Hickman SJ, Sergott R, Conger A, Salter A, Krumwiede KH, Frohman TC, Balcer L, Zivadinov R. Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis. Archives of Neurology. 65: 26-35. PMID 18195137 DOI: 10.1001/Archneurol.2007.10  0.342
2008 Reich DS, Zackowski KM, Gordon-Lipkin EM, Smith SA, Chodkowski BA, Cutter GR, Calabresi PA. Corticospinal tract abnormalities are associated with weakness in multiple sclerosis. Ajnr. American Journal of Neuroradiology. 29: 333-9. PMID 17974617 DOI: 10.3174/Ajnr.A0788  0.63
2008 Hua K, Zhang J, Wakana S, Jiang H, Li X, Reich DS, Calabresi PA, Pekar JJ, van Zijl PC, Mori S. Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage. 39: 336-47. PMID 17931890 DOI: 10.1016/J.Neuroimage.2007.07.053  0.532
2007 Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology. 69: 2085-92. PMID 18040015 DOI: 10.1212/01.Wnl.0000294876.49861.Dc  0.434
2007 Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 69: 1603-9. PMID 17938370 DOI: 10.1212/01.Wnl.0000295995.46586.Ae  0.631
2007 Wu GF, Schwartz ED, Lei T, Souza A, Mishra S, Jacobs DA, Markowitz CE, Galetta SL, Nano-Schiavi ML, Desiderio LM, Cutter GR, Calabresi PA, Udupa JK, Balcer LJ. Relation of vision to global and regional brain MRI in multiple sclerosis. Neurology. 69: 2128-35. PMID 17881718 DOI: 10.1212/01.Wnl.0000278387.15090.5A  0.44
2007 Reich DS, Smith SA, Zackowski KM, Gordon-Lipkin EM, Jones CK, Farrell JA, Mori S, van Zijl PC, Calabresi PA. Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage. 38: 271-9. PMID 17870615 DOI: 10.1016/J.Neuroimage.2007.07.049  0.608
2007 Calabresi PA. Investigating glatiramer acetate for relapsing-remitting multiple sclerosis at the double dose--is more better? Nature Clinical Practice. Neurology. 3: 540-1. PMID 17768411 DOI: 10.1038/Ncpneuro0612  0.407
2007 Calabresi PA, Giovannoni G, Confavreux C, Galetta SL, Havrdova E, Hutchinson M, Kappos L, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, Stuart WH, Lublin FD, et al. The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology. 69: 1391-403. PMID 17761550 DOI: 10.1212/01.Wnl.0000277457.17420.B5  0.315
2007 Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, et al. Health-related quality of life in multiple sclerosis: effects of natalizumab. Annals of Neurology. 62: 335-46. PMID 17696126 DOI: 10.1002/Ana.21163  0.376
2007 Cudrici C, Ito T, Zafranskaia E, Niculescu F, Mullen KM, Vlaicu S, Judge SI, Calabresi PA, Rus H. Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis. Experimental and Molecular Pathology. 83: 198-206. PMID 17662270 DOI: 10.1016/J.Yexmp.2007.05.006  0.309
2007 DeBoy CA, Zhang J, Dike S, Shats I, Jones M, Reich DS, Mori S, Nguyen T, Rothstein B, Miller RH, Griffin JT, Kerr DA, Calabresi PA. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain : a Journal of Neurology. 130: 2199-210. PMID 17557778 DOI: 10.1093/Brain/Awm122  0.574
2007 Balcer LJ, Galetta SL, Calabresi PA, Confavreux C, Giovannoni G, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Miller DH, O'Connor PW, Phillips JT, Polman CH, Radue EW, Rudick RA, et al. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology. 68: 1299-304. PMID 17438220 DOI: 10.1212/01.Wnl.0000259521.14704.A8  0.37
2006 Reich DS, Smith SA, Jones CK, Zackowski KM, van Zijl PC, Calabresi PA, Mori S. Quantitative characterization of the corticospinal tract at 3T. Ajnr. American Journal of Neuroradiology. 27: 2168-78. PMID 17110689  0.505
2006 Smith SA, Farrell JA, Jones CK, Reich DS, Calabresi PA, van Zijl PC. Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: feasibility and application. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 56: 866-75. PMID 16964602 DOI: 10.1002/Mrm.21035  0.578
2006 Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, Burger P, Reich DS, Calabresi PA, Nath A. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology. 67: 383-8. PMID 16894096 DOI: 10.1212/01.Wnl.0000227922.22293.93  0.542
2006 Pulicken M, Koteish A, DeBusk K, Calabresi PA. Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy. Neurology. 66: 1954-5. PMID 16801674 DOI: 10.1212/01.Wnl.0000219764.27182.C7  0.358
2006 Mullen KM, Rozycka M, Rus H, Hu L, Cudrici C, Zafranskaia E, Pennington MW, Johns DC, Judge SI, Calabresi PA. Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system. Annals of Neurology. 60: 118-27. PMID 16729292 DOI: 10.1002/Ana.20884  0.359
2006 Wang T, Allie R, Conant K, Haughey N, Turchan-Chelowo J, Hahn K, Rosen A, Steiner J, Keswani S, Jones M, Calabresi PA, Nath A. Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1209-11. PMID 16636104 DOI: 10.1096/Fj.05-5022Fje  0.304
2006 Irani DN, Anderson C, Gundry R, Cotter R, Moore S, Kerr DA, McArthur JC, Sacktor N, Pardo CA, Jones M, Calabresi PA, Nath A. Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Annals of Neurology. 59: 237-47. PMID 16437581 DOI: 10.1002/Ana.20786  0.389
2006 Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 113: 324-32. PMID 16406539 DOI: 10.1016/J.Ophtha.2005.10.040  0.414
2005 Rus H, Pardo CA, Hu L, Darrah E, Cudrici C, Niculescu T, Niculescu F, Mullen KM, Allie R, Guo L, Wulff H, Beeton C, Judge SI, Kerr DA, Knaus HG, ... ... Calabresi PA, et al. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proceedings of the National Academy of Sciences of the United States of America. 102: 11094-9. PMID 16043714 DOI: 10.1073/Pnas.0501770102  0.393
2005 Allie R, Hu L, Mullen KM, Dhib-Jalbut S, Calabresi PA. Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy. Archives of Neurology. 62: 889-94. PMID 15956159 DOI: 10.1001/Archneur.62.6.889  0.374
2005 Rice GP, Hartung HP, Calabresi PA. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology. 64: 1336-42. PMID 15851719 DOI: 10.1212/01.Wnl.0000158329.30470.D0  0.4
2005 Pulicken M, Bash CN, Costello K, Said A, Cuffari C, Wilterdink JL, Rogg JM, Mills P, Calabresi PA. Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 11: 169-74. PMID 15794390 DOI: 10.1191/1352458505Ms1141Oa  0.351
2003 Frohman EM, Goodin DS, Calabresi PA, Corboy JR, Coyle PK, Filippi M, Frank JA, Galetta SL, Grossman RI, Hawker K, Kachuck NJ, Levin MC, Phillips JT, Racke MK, Rivera VM, et al. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 61: 602-11. PMID 12963748 DOI: 10.1212/01.Wnl.0000082654.99838.Ef  0.448
2003 Sriram S, Yao SY, Stratton C, Calabresi P, Mitchell W, Ikejima H, Yamamoto Y. Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid of Patients with clinically definite and monosymptomatic multiple sclerosis. Clinical and Diagnostic Laboratory Immunology. 9: 1332-7. PMID 12414770 DOI: 10.1128/Cdli.9.6.1332-1337.2002  0.413
2003 Wulff H, Calabresi PA, Allie R, Yun S, Pennington M, Beeton C, Chandy KG. Erratum: The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS (Journal of Clinical Investigation (2003) 111 (1703-1713)) Journal of Clinical Investigation. 112. DOI: 10.1172/Jci200316921E  0.312
2002 Calabresi PA, Austin H, Racke MK, Goodman A, Choyke P, Maloni H, McFarland HF. Impaired renal function in progressive multiple sclerosis. Neurology. 59: 1799-801. PMID 12473777 DOI: 10.1212/01.Wnl.0000036618.68674.7A  0.363
2002 Calabresi PA. Considerations in the treatment of relapsing-remitting multiple sclerosis. Neurology. 58: S10-22. PMID 11971122 DOI: 10.1212/Wnl.58.8_Suppl_4.S10  0.368
2002 Calabresi PA, Wilterdink JL, Rogg JM, Mills P, Webb A, Whartenby KA. An open-label trial of combination therapy with interferon beta-1a and oral methotrexate in MS. Neurology. 58: 314-7. PMID 11805267 DOI: 10.1212/Wnl.58.2.314  0.342
2001 Calabresi PA, Prat A, Biernacki K, Rollins J, Antel JP. T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells. Journal of Neuroimmunology. 115: 161-7. PMID 11282166 DOI: 10.1016/S0165-5728(01)00253-3  0.368
1999 Calabresi PA, Martin R, Jacobson S. Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis. Journal of Neurovirology. 5: 102-8. PMID 10190696 DOI: 10.3109/13550289909029751  0.408
1998 Calabresi PA, Fields NS, Farnon EC, Frank JA, Bash CN, Kawanashi T, Maloni H, Jacobson S, McFarland HF. ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions. Journal of Neuroimmunology. 85: 212-9. PMID 9630170 DOI: 10.1016/S0165-5728(98)00008-3  0.309
1997 Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Medicine. 3: 1394-7. PMID 9396611 DOI: 10.1038/Nm1297-1394  0.394
1996 McFarland HF, Stone LA, Calabresi PA, Maloni H, Bash CN, Frank JA. MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies. Multiple Sclerosis (Houndmills, Basingstoke, England). 2: 198-205. PMID 9345374 DOI: 10.1177/135245859600200406  0.489
1996 Calabresi PA, Stone LA, Bash CN, Frank JA, McFarland HF. Interferon beta results in immediate improvement of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI Multiple Sclerosis Journal. 2: 251-251. DOI: 10.1177/135245859600200515  0.384
Show low-probability matches.